Expertise in
3
conditions

Xun Y. Xu

No 300, Guangzhou Road, 
Nanjing, CN 
Expertise in
3
conditions
No 300, Guangzhou Road, 
Nanjing, CN 

Overview

Xun Xu practices practicing medicine in Nanjing, China.

Xu is highly rated in 3 conditions, according to our data. Their clinical expertise encompasses Triploidy, Atrial Tachycardia, Nearsightedness, Intrauterine Device Insertion, and Vitrectomy.

They are actively involved in clinical research, co-authoring 709 peer reviewed articles and participating in 2 clinical trials.

Locations

No 300, Guangzhou Road, Nanjing, 210029, China
Other Locations
No. 246 Heping Road, Hefei, 230011, China
800 Dong Chuan Rd, Shanghai, 200240, China
Zhu Yu Wan Road 888, Yangzhou, 225009, China
No. 300, Guangzhou Rd, Nanjing, 210009, China
No. 100 Haining Road, Shanghai, 200080, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1, Safety, Tolerability and Pharmacokinetic Profile Study of Intravitreous Injections of HB002.1M (a Vascular Endothelial Growth Factor Receptor Decoy) in Subjects With Neovascular Age-Related Macular Degeneration
A Phase 1, Safety, Tolerability and Pharmacokinetic Profile Study of Intravitreous Injections of HB002.1M (a Vascular Endothelial Growth Factor Receptor Decoy) in Subjects With Neovascular Age-Related Macular Degeneration
Enrollment Status: Completed
Publish Date: July 29, 2020
Intervention Type: Drug
Study Phase: Phase 1
A Randomized, Double-blind, Two-group Parallel, Positive-controlled Clinical Phase I Trial Comparing the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet Age-related Macular Degeneration.
A Randomized, Double-blind, Two-group Parallel, Positive-controlled Clinical Phase I Trial Comparing the Safety, Pharmacokinetics and Pharmacodynamics of QL1205 and Lucentis® in Patients With Wet Age-related Macular Degeneration.
Enrollment Status: Completed
Publish Date: April 11, 2019
Intervention Type: Drug
Study Phase: Phase 1
View 1 Less Clinical Trial

707 Total Publications

Bringing human early embryo development to clinical interpretation: HESTA as an evolving reference.
Bringing human early embryo development to clinical interpretation: HESTA as an evolving reference.
Journal: Clinical and translational medicine
Published: August 24, 2026

Frequently Asked Questions about Xun Y. Xu

Is Xun Y. Xu a top-rated expert for Triploidy?

MediFind is an objective health platform that identifies experts based on real-world data. Xun Y. Xu is classified as an Advanced expert for Triploidy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Xun Y. Xu participate in research or clinical trials?

Yes. Xun Y. Xu has published 707 articles and abstracts on conditions like Triploidy. You can view a list of Xun Y. Xu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Xu's expertise for a condition
ConditionClose
      View All 78 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile